Skip to content

A randomized parallel controlled trial to investigate the feasibility of intravenous lidocaine to reduce the dose of propofol for anesthesia induction in outpatient abortion and uterine curettage surgery and the optimal dose combination.

A randomized parallel controlled trial to investigate the feasibility of intravenous lidocaine to reduce the dose of propofol for anesthesia induction in outpatient abortion and uterine curettage surgery and the optimal dose combination.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049263
Enrollment
Unknown
Registered
2021-07-28
Start date
2021-09-27
Completion date
Unknown
Last updated
2022-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Experimental group A:Intravenous 2% lidocaine 0.5 mg/kg was given before propofol induction
Experimental group B:Intravenous 2% lidocaine 1 mg/kg was given before propofol induction
Experimental group C:Intravenous 2% lidocaine 1.5 mg/kg was given before propofol induction
Control group D:Intravenous injection of the same amount of normal saline is given before propofol induction

Sponsors

West China Second Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Patients with ASA I to II, aged 18-50 years, fasting for 6 hours, and no drinking for 2 hours, who are planning to undergo outpatient abortion and uterine curettage surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with BMI >28 kg/m^2 or BMI<18 kg/m^2 and patients with body weight <40kg. 2. Patients who are allergic to local anesthetics, propofol, fentanil or other drugs related to this study. 3. Patients with severe liver and kidney dysfunction, endocrine disease, metabolic disease, cardiovascular disease, respiratory system disease or central nervous system disease. 4. Patients who have taken sedatives, analgesics, and drugs that may affect the metabolism of local anesthetics for a long time or within 7 days, or patients who have taken other experimental drugs or participated in other clinical trials within 3 months before the study. 5.Patients who are addicted to alcohol or drugs.

Design outcomes

Primary

MeasureTime frame
Whether the patient achieves adequate sedation (MOAA/S score <1) after propofol induction, and whether the patient is physically active during or before dilation;

Secondary

MeasureTime frame
Propofol used in total;Ramsay upper airway obstruction score;Duration of operation;The time from the end of the operation to the opening of the eyes;Hypoxemia (SPO260s);

Countries

China

Contacts

Public ContactNi Juan

West China Second Hospital of Sichuan University

nijuankiki@163.com+86 18180609890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026